Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001193125-24-201342
Filing Date
2024-08-15
Accepted
2024-08-15 16:30:49
Documents
1
Period of Report
2024-06-30
Effectiveness Date
2024-08-15

Document Format Files

Seq Description Document Type Size
1 NT 10-Q d826227dnt10q.htm NT 10-Q 22384
  Complete submission text file 0001193125-24-201342.txt   23521
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-41390 | Film No.: 241212859
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)